Nafamostat Efficacy in Phase 3 Registrational CRRT Study

Clinical trial NCT06150742 · RECRUITING

Trial details

NCT number: NCT06150742
Sponsor: Talphera, Inc
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Kidney Injury

Start date: 2024-08-15
Primary completion: 2025-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.